Skip to main content
Equibles

SOLARA · Solara Active Pharma Sciences Limited · Financials

Use SOLARA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SOLARA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
689.65 INR +13.40 (+1.98%) At close · Nov 13
Rebalance outlook locked
Market Cap
33.15B INR
Shares
48.07M
Volume · Nov 13 543.51K Avg daily vol (3M) 592.86K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
13.69B +6.6%
FY2026 Revenue FY2019–FY2026
Net Income
-74.1M -1472.2%
FY2026 Net Income FY2019–FY2026
Operating Cash Flow
1.53B -28.2%
FY2026 Operating Cash Flow FY2022–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item TTM FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
INR 15.35B 13.69B 12.84B 12.89B 14.44B 12.68B 16.17B 13.22B 13.87B
INR 1.05B 996.8M 992.5M 1.03B 1.11B 1.12B 1.09B 941.6M 830.9M
INR 894.4M 947.5M 1.15B 1.05B 900.6M 752.8M 844.8M 778.9M 824.2M
INR 369.4M -74.1M 5.4M -4.88B -448.1M -911M 2.22B 1.15B 676.8M
INR 0 0 0 785.4M -225.7M -328.1M 1.5M 3.9M 5.8M
INR 369.4M -74.1M 5.4M -5.67B -221.7M -581.5M 2.21B 1.11B 594.2M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 107.8M in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.